Page 52 - Tyrosine-Based Bioconjugations - Jorick Bruins

Chapter 2
(19) Long, M. J. C., and Hedstrom, L., Mushroom tyrosinase oxidizes tyrosine-rich sequences to allow selective protein functionalization. ChemBioChem 2012, 13 (12), 1818-25.
(20) Faccio, G., Kampf, M. M., Piatti, C., Thony-Meyer, L., and Richter, M., Tyrosinase-catalyzed
site-specific immobilization of engineered C-phycocyanin to surface. Sci. Rep. 2014, 4,
5370.
(21) Ito, S., Kato, T., Shinpo, K., and Fujita, K., Oxidation of tyrosine residues in proteins by
tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-
3,4-dihydroxyphenylalanine. Biochem. J. 1984, 222 (2), 407-11.
(22) Tabakovic, K., and Abul-Hajj, Y. J., Reaction of lysine with estrone 3,4-o-quinone. Chem.
Res. Toxicol. 1994, 7 (5), 696-701.
(23) Xu, R., Huang, X., Morgan, T. D., Prakash, O., Kramer, K. J., and Hawley, M. D.,
Characterization of products from the reactions of N-acetyldopamine quinone with N-
acetylhistidine. Arch. Biochem. Biophys. 1996, 329 (1), 56-64.
(24) Borrmann, A., Fatunsin, O., Dommerholt, J., Jonker, A. M., Lowik, D. W. P. M., van Hest, J.
C. M., and van Delft, F. L., Strain-promoted oxidation-controlled cyclooctyne-1,2-quinone cycloaddition (SPOCQ) for fast and activatable protein conjugation. Bioconjugate Chem. 2015, 26 (2), 257-61.
(25) Jonker, A. M., Borrmann, A., van Eck, E. R., van Delft, F. L., Lowik, D. W., and van Hest, J. C., A fast and activatable cross-linking strategy for hydrogel formation. Adv. Mater. 2015, 27 (7), 1235-40.
(26) Dommerholt, J., Schmidt, S., Temming, R., Hendriks, L. J. A., Rutjes, F. P. J. T., van Hest, J. C. M., Lefeber, D. J., Friedl, P., and van Delft, F. L., Readily accessible bicyclononynes for bioorthogonal labeling and three-dimensional imaging of living cells. Angew. Chem. Int. Ed. 2010, 49 (49), 9422-5.
(27) Przybysz, A., Volmer, A. A., Westphal, A. H., and van Berkel, W. J., Bifunctional immobilization of a hyperthermostable endo-beta-1,3-glucanase. Appl. Microbiol. Biotechnol. 2014, 98 (3), 1155-63.
(28) Wagner, K., Kwakkenbos, M. J., Claassen, Y. B., Maijoor, K., Bohne, M., van der Sluijs, K. F., Witte, M. D., van Zoelen, D. J., Cornelissen, L. A., Beaumont, T., et al., Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity. Proc. Natl. Acad. Sci. U. S. A. 2014, 111 (47), 16820-5.
(29) Dorywalska, M., Strop, P., Melton-Witt, J. A., Hasa-Moreno, A., Farias, S. E., Casas, M. G., Delaria, K., Lui, V., Poulsen, K., Loo, C., et al., Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates. Bioconjugate Chem. 2015, 26 (4), 650-9.
(30) Chari, R. V., Miller, M. L., and Widdison, W. C., Antibody-drug conjugates: an emerging concept in cancer therapy. Angew. Chem. Int. Ed. 2014, 53 (15), 3796-827.
(31) Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., and Forero-Torres, A., Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N. Engl. J. Med. 2010, 363 (19), 1812-21.
(32) Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D. Y., Dieras, V., Guardino, E., et al., Trastuzumab emtansine for HER2-positive advanced breast cancer. N. Engl. J. Med. 2012, 367 (19), 1783-91.
50